Omicron, delta, and beta, deadliest among SARS-CoV-2 variants: an in silico analysis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Science in Microbiology, 2023.
Päätekijä: | Bosu, Sagar |
---|---|
Muut tekijät: | Hasanuzzaman, Md. |
Aineistotyyppi: | Opinnäyte |
Kieli: | English |
Julkaistu: |
Brac University
2023
|
Aiheet: | |
Linkit: | http://hdl.handle.net/10361/19124 |
Samankaltaisia teoksia
-
An in-silico approach to design a vaccine against beta lactamase enzyme of mycobacterium tuberculosis
Tekijä: Meem, Fatiha Soumaiya
Julkaistu: (2024) -
An in Silico approach to multi-epitope subunit vaccine development against SARS COV-2 using Membrane Glycoprotein
Tekijä: Rafsan, Rian
Julkaistu: (2021) -
In-silico based vaccine development: targeting nucleocapsid protein of SARS-CoV-2.
Tekijä: Iva, Yesmine Akter
Julkaistu: (2022) -
Overview of the risk factors, prevention and management of SARS-COV-2
Tekijä: Mustafa, Nashrah
Julkaistu: (2021) -
Potential benefits of heterologous mixture of COVID 19 vaccinations from different manufacturers
Tekijä: Pranto, Hasan Al Reza
Julkaistu: (2022)